Well, maybe just a straight CR after I was reminded again of the tricky wording the Board use for CRs in the past.
I just would have thought though they could easily swap out the current financing debt to something much cheaper given the risk profile has changed significantly. Given their efforts to minimise shorter activity as well as maintaining control of the company through SI/GG holding, this would be a logical step before a full blown CR.
- Forums
- ASX - By Stock
- MSB
- Ann: Pause in Trading
MSB
mesoblast limited
Add to My Watchlist
2.33%
!
$1.78

Ann: Pause in Trading, page-63
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.78 |
Change
-0.043(2.33%) |
Mkt cap ! $2.287B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $6.089M | 3.408M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 27425 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 51741 | 38 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 30522 | 1.780 |
21 | 32371 | 1.775 |
10 | 35396 | 1.770 |
15 | 109297 | 1.765 |
10 | 64592 | 1.760 |
Price($) | Vol. | No. |
---|---|---|
1.785 | 32330 | 28 |
1.790 | 42891 | 14 |
1.795 | 55445 | 10 |
1.800 | 47204 | 9 |
1.805 | 93304 | 7 |
Last trade - 12.01pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online